References
- Dunnill M S. The pathology of asthma with special reference to changes in bronchial mucosa. J Clin Pathol 1960; 33: 27–33
- Marini M, Avoni E, Hollemborg J, Mattoli S. Cytokine mRNA profile and cell activation in bronchoalveolar lavage fluid from nonatopic patients with symptomatic asthma. Chest 1992; 102(3)661–669
- Calhoun W J, Jarjour N N, Gleich G J, Stevens C A, Busse W W. Increased airway inflammation with segmental versus aerosol antigen challenge. Am Rev Respir Dis 1993; 147: 1465–1471
- Melewicz F M, Kline L E, Cohen A B, Spiegelberg H L. Characterization of Fc receptors for IgE on human alveolar macrophages. Clin Exp Immunol 1982; 49: 367–370
- Carroll M P, Curham S R, Walsh G. Activation of neutrophils and monocytes after allergen‐and histamine‐induced bronchoconstriction. J Allergy Clin Immunol 1985; 75: 290–296
- Wardlaw A J, Hay Helen, Cromwell O, Collins J V, Kay A B. Leukotrienes, LTC4 and LTB4 in bronchoalveolar lavage in bronchial asthma and other diseases. J Allergy Clin Immunol 1989; 84: 19–26
- Resnick M B, Weller F P. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 1993; 8: 349–355
- Borish L, Mascali J J, Dishuck J, Beam W R, Martin R J, Rosenwasser L J. Detection of alveolar macrophagederived IL‐1β in asthma. Inhibition with corticosteroids. J Immunol 1992; 149: 3078–3082
- Mattoli S, Mattoso V L, Soloperto M, Allegra L, Fasoli A. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J Allergy Clin Immunol 1991; 87: 794–802
- Hallsworth M P, Soh C PC, Lane S J, Arm J P, Lee T H. Selective enhancement of GM‐CSF, TNF‐alfa, IL‐1β and IL‐8 production by monocytes and macrophages of asthmatic subjects. Eur Respir J 1994; 7: 1096–1102
- Bevilacqua M P, Pober J S, Wheeler M E, Cotran R S, Gimbrone M A. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related cell lines. J Clin Invest 1985; 76: 2003–2011
- Johnson M. β2‐Agonists as anti‐inflammatory therapies in the lung. Agents Actions 1993; 41: 27–49, (Suppl)
- Anderson G. Pharmacology of formoterol: an innovative bronchodilator. Agents Actions 1991; 34: 97–115
- Hjemdahl P, Larsson K, Johansson M ‐C, Zetterlund A, Eklund A. β‐Adrenoceptors in human alveolar macrophages isolated by elutriation. Br J Clin Pharmacol 1990; 30: 673–682
- Ligget S B. Identification and characterization of a homogeneous population of β2‐adrenergic receptors on human alveolar macrophages. Am Rev Respir Dis 1989; 139: 552–555
- Labarca C, Paigen K. A simple rapid and sensitive DNA assay procedure. Anal Biochem 1980; 102: 344–352
- Werb Z, Foley R, Munck A. Interactions of glucocorticoids with macrophages. Identification of glucocorticoid receptors in monocytes and macrophages. J Exp Med 1978; 147: 1684
- Knudsen P, Dinarello C, Strom T. Glucocorticoids inhibit transcriptional and posttranscriptional expression of interleukin 1 in U937 cells. J Immunol 1987; 139: 4129–4134
- Kern J, Lamb R, Reed J. Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. J Clin Invest 1988; 81: 237–244
- Linden M, Brattsand R. Effects of a corticosteroid, budesonide, on alveolar macrophage and blood monocyte secretion of cytokines: Differential sensitivity of GM‐CSF, IL‐1β and IL‐6. Pulmon Pharmacol 1994; 7: 43–47
- Strieter R M. Differential regulation of tumor necrosis factor‐a in human alveolar macrophages and periferal blood monocytes: A cellular and molecular analysis. Am J Respir Cell Mol Biol 1989; 1: 57–63
- Linden M. The effect of β2‐adrenoceptor agonists and a corticosteroid, budesonide, on the secretion of inflammatory mediators from monocytes. Br J Pharmacol 1992; 207: 156–160
- Sebaldt R J, Sheller J R, Oates J A, Jackson Roberts L. Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc Natl Acad Sci 1990; 87: 6974–6978
- Freeland H S, Pipkorn U, Schleimer R P. Leukotriene B4 as a mediator of early and late reactions to antigens in humans: The effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol 1989; 83: 634–642
- Seggev J S, Thornton W H, Edes T E. Serum leukotriene B4 levels in patients with obstructive pulmonary disease. Chest 1991; 99: 289–291
- Dworski R, Fitzgerald G A, Oates J A, Sheller J R. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994; 149: 953–959
- Assem E SK, Schild H O. Inhibition by sympathomimetic amines of histamine release induced by antigen in passively sensitized human lung. Nature 1964; 224: 1028–1029
- Grönneberg R, Zetterström O. Inhibition of anti‐IgE induced skin response in normals by formoterol, a new β2‐adrenoceptor agonist, and terbutaline. 2. Effect on the late phase reaction. Allergy 1990; 45: 340–346
- Twentyman O P, Finnerty J P, Harris A, Palmer J, Hoigate S T. Protection against allergen‐induced asthma by salmeterol. Lancet 1990; 336: 1338–1342
- Britton J, Pavord I, Wong C. β2‐agonists in asthma. Lancet 1991; 337: 301–302
- Baker A J, Palmer J, Johnson M, Fuller R W. Inhibitory actions of salmeterol on human airway macrophages and blood monocytes. Eur J Pharmacol 1994; 264: 301–306
- Martin T R, Goodman R B. The role of lung mononuclear cells in asthma. Immunol Allergy Clin North Am 1990; 10: 295–308
- Martin T R, Altman R C, Albert R K. Leukotriene B4 production by human alveolar macrophage: a potential mechanism for amplifying inflammation in lung. Am Rev Respir Dis 1984; 129: 106–111
- Johnson M. The pharmacology of salmeterol. Lung 1990; 168: 115–119